Metrics Contract Services Installs High Shear Mixer from ACG Engineering in NC Facility

Metrics Contract Services has completed the installation of a new high shear mixer from ACG Engineering at its facility in Greenville, North Carolina. A division of Mayne Pharma, Metrics is utilizing the QUEST HSM III granulator to assist ongoing efforts in transitioning formulations from initial development to the process validation stage and, ultimately, to commercial production.

The QUEST HSM III was developed jointly with Xertecs, ACG’s European Innovation and Design Centre. The QUEST HSM III incorporates 12-bar pressure shock resistance and ACG’s signature X-ONE COMMAND™ process control system. Designed to facilitate compliance with cGMP standards, the versatile QUEST HSM III features interchangeable process bowls of 15, 30 and 65 liters providing a wide range of batch sizes and torque measurement instrumentation for process end point determination.

The new ACG mixer/granulator features a multi-blade chopper and Z-shaped impeller for better granules and shorter process times, and the machine’s unique sealing concept eliminates the need for compressed air. The unit is both ergonomic and safe: its innovative wrap-around design makes all crucial components optimally accessible to operators, while its patent-pending Maximum Operational Safety Technology™ (MOST) offers unsurpassed user protection.

“The new ACG Quest HSM-II Granulator imparts flexibility to use three different size bowls, to accommodate granulation batch sizes from 3kg to approximately 25kg,” said Brad Gold, Vice President of Pharmaceutical Development for Metrics Contract Services. “Moreover, its slip ring technology affords us the ability to measure the force acting on the rotating impeller shaft.  It provides a sensitive measure of granulation endpoint and, just as important, provides scale-up data during tech transfer.”

For Metrics Contracting Services, the new granulator is part of Mayne Pharma Inc.’s recent $80 million investment in the Greenville site. Infrastructure upgrades include a new, 126,000-sq-ft, oral dose commercial manufacturing facility adjacent the existing plant, allowing the original space to grow its contract analytical laboratory, formulation development and CTM services capacity.

  • <<
  • >>